Article

TERT Promoter Mutations in Penile Squamous Cell Carcinoma: High Frequency in Non-HPV-related Type and Association With Favorable Clinicopathologic Features

2020-07-17

Abstract excerpt

<h4>Background: </h4> Penile carcinoma is a rare malignant neoplasm and its molecular pathogenetic mechanism is largely unknown. Telomerase reverse transcriptase ( TERT ) promoter mutations have been detected in several types of human malignancies, including malignant melanoma, non-melanoma skin cancer, thyroid carcinoma, glioma, and bladder carcinoma. However, TERT -p mutation in penile squamous cell carcinoma (S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e40e622a-99fa-5353-b998-4f837d19271e
DOI: 10.21203/rs.3.rs-43639/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

TERT Promoter Mutations in Penile Squamous Cell Carcinoma: High Frequency in Non-HPV-related Type and Association With Favorable Clinicopathologic FeaturesDOI 10.21203/rs.3.rs-43639/v1Read

TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.Semantic proximity Read

Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.Semantic proximity Read

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.Semantic proximity Read

TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.Semantic proximity Read

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.Semantic proximity Read

Mutations in the telomerase reverse transcriptase promoter and PIK3CA gene are common events in penile squamous cell carcinoma of Italian and Ugandan patients.Semantic proximity Read

A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.Semantic proximity Read

High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.Semantic proximity Read

High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.Semantic proximity Read

Highly prevalent<i>TERT</i>promoter mutations in bladder cancer and glioblastomaSemantic proximity Read

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.Semantic proximity Read

Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management.Semantic proximity Read